Pulmonx logo

Pulmonx Share Price Today

(NASDAQ: LUNG)

Pulmonx share price is $6.43 & ₹563.11 as on 7 Feb 2025, 2.30 'hrs' IST

$6.43

0.28

(4.55%)

Market is closed - opens 8 PM, 07 Feb 2025

View live Pulmonx share price in Dollar and Rupees. Guide to invest in Pulmonx stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pulmonx, along with analyst recommendations, forecasts, and comprehensive financials.

Pulmonx share price movements

  • Today's Low: $6.18
    Today's High: $6.45

    Day's Volatility :4.19%

  • 52 Weeks Low: $5.46
    52 Weeks High: $14.84

    52 Weeks Volatility :63.2%

Pulmonx (LUNG) Returns

PeriodPulmonx CorpSector (Health Care)Index (Russel 2000)
3 Months
-13.58%
-1.3%
0.0%
6 Months
15.03%
0.8%
0.0%
1 Year
-55.1%
1.9%
0.0%
3 Years
-76.86%
11.4%
-12.1%

Pulmonx (LUNG) Key Statistics

in dollars & INR

Previous Close
$6.15
Open
$6.16
Today's High
$6.45
Today's Low
$6.18
Market Capitalization
$253.9M
Today's Volume
$136.3K
52 Week High
$14.835
52 Week Low
$5.46
Revenue TTM
$79.3M
EBITDA
$-55.0M
Earnings Per Share (EPS)
$-1.47
Profit Margin
-72.01%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-51.99%

How to invest in Pulmonx Stock (LUNG) from India?

It is very easy for Indian residents to invest directly in Pulmonx from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pulmonx stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pulmonx or LUNG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pulmonx or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pulmonx shares which would translate to 0.136 fractional shares of Pulmonx as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pulmonx, in just a few clicks!

Returns in Pulmonx (LUNG) for Indian investors in Rupees

The Pulmonx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pulmonx investment value today

Current value as on today

₹50,487

Returns

₹49,513

(-49.51%)

Returns from Pulmonx Stock

₹55,098 (-55.1%)

Dollar Returns

₹5,585 (+5.58%)

Indian investors sentiment towards Pulmonx (LUNG)

14%

Period: Jan 7, 2025 to Feb 6, 2025. Change in 30 Days versus previous period

Search interest for Pulmonx Stock from India on INDmoney has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pulmonx

  • FMR Inc

    14.87%

  • PRIMECAP Management Company

    14.37%

  • Morgan Stanley - Brokerage Accounts

    9.60%

  • BlackRock Inc

    7.08%

  • Vanguard Group Inc

    5.77%

  • JPMorgan Chase & Co

    5.35%

Analyst Recommendation on Pulmonx

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Pulmonx(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
10
11
Hold
2
2
1
Sell
0
0
0

Analyst Forecast on Pulmonx Stock (LUNG)

What analysts predicted

Upside of 80.14%

Target:

$11.58

Current:

$6.43

Insights on Pulmonx Stock (Ticker Symbol: LUNG)

  • Price Movement

    In the last 7 days, LUNG stock has moved up by 13.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 20.78M → 20.38M (in $), with an average decrease of 1.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -15.32M → -14.14M (in $), with an average increase of 8.4% per quarter
  • LUNG vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 61.0% return, outperforming this stock by 116.6%
  • LUNG vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 144.7% return, outperforming this stock by 220.8%
  • Price to Sales

    ForLUNG every $1 of sales, investors are willing to pay $3.1, whereas for Boston Scientific Corp., the investors are paying $9.7 for every $1 of sales.

LUNG Pulmonx Financials in INR & Dollars

FY18Y/Y Change
Revenue
$20.0M
-
Net Income
$-18.5M
↑ 244.16%
Net Profit Margin
-92.38%
-
FY19Y/Y Change
Revenue
$32.6M
↑ 62.94%
Net Income
$-20.7M
↑ 12.04%
Net Profit Margin
-63.52%
↑ 28.86%
FY20Y/Y Change
Revenue
$32.7M
↑ 0.42%
Net Income
$-32.2M
↑ 55.68%
Net Profit Margin
-98.47%
↓ 34.95%
FY21Y/Y Change
Revenue
$48.4M
↑ 47.91%
Net Income
$-48.7M
↑ 50.98%
Net Profit Margin
-100.51%
↓ 2.04%
FY22Y/Y Change
Revenue
$53.7M
↑ 10.84%
Net Income
$-58.9M
↑ 21.09%
Net Profit Margin
-109.8%
↓ 9.29%
FY23Y/Y Change
Revenue
$68.7M
↑ 27.98%
Net Income
$-60.8M
↑ 3.26%
Net Profit Margin
-88.6%
↑ 21.2%
Q2 FY23Q/Q Change
Revenue
$17.2M
↑ 18.29%
Net Income
$-16.2M
↑ 2.11%
Net Profit Margin
-94.19%
↑ 14.93%
Q3 FY23Q/Q Change
Revenue
$17.7M
↑ 2.76%
Net Income
$-14.9M
↓ 8.0%
Net Profit Margin
-84.33%
↑ 9.86%
Q4 FY23Q/Q Change
Revenue
$19.3M
↑ 9.11%
Net Income
$-13.9M
↓ 6.79%
Net Profit Margin
-72.04%
↑ 12.29%
Q1 FY24Q/Q Change
Revenue
$18.9M
↓ 2.2%
Net Income
$-13.7M
↓ 1.0%
Net Profit Margin
-72.92%
↓ 0.88%
Q2 FY24Q/Q Change
Revenue
$20.8M
↑ 10.23%
Net Income
$-15.3M
↑ 11.47%
Net Profit Margin
-73.74%
↓ 0.82%
Q3 FY24Q/Q Change
Revenue
$20.4M
↓ 1.91%
Net Income
$-14.1M
↓ 7.71%
Net Profit Margin
-69.38%
↑ 4.36%
FY18Y/Y Change
Profit
$12.3M
-
FY19Y/Y Change
Profit
$22.4M
↑ 82.44%
FY20Y/Y Change
Profit
$21.2M
↓ 5.41%
FY21Y/Y Change
Profit
$35.6M
↑ 68.05%
FY22Y/Y Change
Profit
$39.9M
↑ 11.89%
FY23Y/Y Change
Profit
$50.8M
↑ 27.31%
Q2 FY23Q/Q Change
Profit
$12.7M
↑ 20.26%
Q3 FY23Q/Q Change
Profit
$13.0M
↑ 2.32%
Q4 FY23Q/Q Change
Profit
$14.3M
↑ 9.76%
Q1 FY24Q/Q Change
Profit
$14.0M
↓ 2.25%
Q2 FY24Q/Q Change
Profit
$15.3M
↑ 9.51%
Q3 FY24Q/Q Change
Profit
$15.0M
↓ 1.84%
FY18Y/Y Change
Operating Cash Flow
$-18.4M
↑ 296.63%
Investing Cash Flow
$200.0K
↓ 846.24%
Financing Cash Flow
$12.1M
↑ 129.78%
FY19Y/Y Change
Operating Cash Flow
$-20.8M
↑ 12.89%
Investing Cash Flow
$-14.2M
↓ 7216.5%
Financing Cash Flow
$45.6M
↑ 276.58%
FY20Y/Y Change
Operating Cash Flow
$-30.6M
↑ 47.52%
Investing Cash Flow
$12.7M
↓ 189.19%
Financing Cash Flow
$234.8M
↑ 414.77%
FY21Y/Y Change
Operating Cash Flow
$-41.4M
↑ 35.11%
Investing Cash Flow
$-46.3M
↓ 464.38%
Financing Cash Flow
$4.5M
↓ 98.1%
FY22Y/Y Change
Operating Cash Flow
$-45.1M
↑ 8.93%
Investing Cash Flow
$-4.2M
↓ 90.87%
Financing Cash Flow
$2.5M
↓ 44.52%
Q2 FY23Q/Q Change
Operating Cash Flow
$-7.9M
↓ 37.59%
Investing Cash Flow
$-813.0K
↓ 241.64%
Financing Cash Flow
$92.0K
↓ 99.56%

Pulmonx Technicals Summary

Sell

Neutral

Buy

Pulmonx is currently in a neutral trading position according to technical analysis indicators.

Pulmonx (LUNG) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pulmonx Corp logo
-0.92%
15.03%
-55.1%
-76.86%
-83.64%
Medtronic Plc logo
9.85%
10.7%
5.38%
-12.85%
-23.92%
Edwards Lifesciences Corp. logo
-4.26%
9.82%
-17.26%
-36.29%
-6.77%
Boston Scientific Corp. logo
9.45%
37.84%
61.52%
137.82%
148.74%
Stryker Corporation logo
8.78%
20.82%
16.82%
55.26%
82.33%
Abbott Laboratories logo
12.23%
17.95%
14.04%
-0.33%
45.21%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pulmonx Corp logo
NA
NA
NA
-1.56
-0.52
-0.2
NA
2.38
Medtronic Plc logo
27.77
27.77
1.56
5.45
0.08
0.04
0.03
38.29
Edwards Lifesciences Corp. logo
27.41
27.41
6.62
2.55
0.19
0.11
NA
16.18
Boston Scientific Corp. logo
86.75
86.75
1.9
2.84
0.09
0.05
NA
14.05
Stryker Corporation logo
51.36
51.36
2.78
13.51
0.19
0.07
0.01
52.86
Abbott Laboratories logo
17.29
17.29
2.37
5.15
0.15
0.06
0.02
22.94
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pulmonx Corp logo
Buy
$253.9M
-83.64%
NA
-72.01%
Medtronic Plc logo
Buy
$116.5B
-23.92%
27.77
12.06%
Edwards Lifesciences Corp. logo
Buy
$41.9B
-6.77%
27.41
65.86%
Boston Scientific Corp. logo
Buy
$154.7B
148.74%
86.75
11.26%
Stryker Corporation logo
Buy
$152.1B
82.33%
51.36
16.34%
Abbott Laboratories logo
Buy
$229.1B
45.21%
17.29
13.99%

About Pulmonx

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Organization
Pulmonx
Employees
279
CEO
Mr. Steven S. Williamson
Industry
Health Technology

Management People of Pulmonx

NameTitle
Mr. David A. Lehman J.D.
General Counsel & Secretary
Mr. Geoffrey Beran Rose
Chief Commercial Officer
Mr. Steven S. Williamson
CEO, President & Director
Mr. Mehul Joshi
Chief Financial Officer
Mr. Sri Radhakrishnan
Chief Technical Officer
Ms. Lauren Cristina
Vice President of Finance & Administration (U.S.)
Ms. Marcee M. Maroney
Vice President of Marketing
Sarah Huber
Vice President of Sales (U.S.)
Ms. Lisa Paul
Chief People Officer
Mr. Jérôme Erath
Senior VP & GM of Europe Middle-East & Africa

Important FAQs about investing in LUNG Stock from India :

What is Pulmonx share price today?

Pulmonx share price today stands at $6.43, Open: $6.16 ; Previous Close: $6.15 ; High: $6.45 ; Low: $6.18 ; 52 Week High: $14.84 ; 52 Week Low: $5.46.

The stock opens at $6.16, after a previous close of $6.15. The stock reached a daily high of $6.45 and a low of $6.18, with a 52-week high of $14.84 and a 52-week low of $5.46.

Can Indians buy Pulmonx shares?

Yes, Indians can invest in the Pulmonx (LUNG) from India.

With INDmoney, you can buy Pulmonx at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pulmonx at zero transaction cost.

How can I buy Pulmonx shares from India?

It is very easy to buy Pulmonx from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pulmonx (LUNG) be purchased?

Yes, you can buy fractional shares of Pulmonx with INDmoney app.

What are the documents required to start investing in Pulmonx stocks?

To start investing in Pulmonx, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pulmonx Stock (LUNG)?

Today’s highest price of Pulmonx (LUNG) is $6.45.

Today’s lowest price of Pulmonx (LUNG) is $6.18.

What is today's market capitalisation of Pulmonx?

Today's market capitalisation of Pulmonx LUNG is 253.9M

What is the 52 Week High and Low Range of Pulmonx Stock (LUNG)?

  • 52 Week High

    $14.84

  • 52 Week Low

    $5.46

What are the historical returns of Pulmonx (LUNG)?

  • 1 Month Returns

    -0.92%

  • 3 Months Returns

    15.03%

  • 1 Year Returns

    -55.1%

  • 5 Years Returns

    -83.64%

Who is the Chief Executive Officer (CEO) of Pulmonx ?

Mr. Steven S. Williamson is the current Chief Executive Officer (CEO) of Pulmonx.